148 related articles for article (PubMed ID: 2788960)
1. [Disorders of the immune system in benign lesions and cancer of the breast].
Derevnina NA; Polevaia EB; Veskova TK; Trubcheninova LP; Bogatyrev VN
Vopr Onkol; 1989; 35(7):810-6. PubMed ID: 2788960
[TBL] [Abstract][Full Text] [Related]
2. [Tumor-induced immunosuppression in breast cancer patients].
Kharkevich DD; Polevaia EB; Kadagidze ZG
Eksp Onkol; 1990; 12(5):53-6. PubMed ID: 2226260
[TBL] [Abstract][Full Text] [Related]
3. Assessment of host immune response in breast cancer patients.
Akimoto M; Ishii H; Nakajima Y; Iwasaki H; Tan M; Abe R; Kasai M
Cancer Detect Prev; 1986; 9(3-4):311-7. PubMed ID: 3488806
[TBL] [Abstract][Full Text] [Related]
4. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
5. [Functional activity of the regional lymph nodes in breast cancer patients].
Loboda VI; Grinevich IuA
Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329
[TBL] [Abstract][Full Text] [Related]
6. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
Nowak JS; Lanzrein C
Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
[TBL] [Abstract][Full Text] [Related]
7. [Lymphocyte subsets and response of breast cancer and benign mammary disease to PHA].
Nakao S; Hayashida K; Hasegawa H; Ishii T; Eida K; Noguchi K
Gan No Rinsho; 1987 Oct; 33(12):1453-8. PubMed ID: 3500331
[TBL] [Abstract][Full Text] [Related]
8. [A mathematical analysis of immunologic indicators in dyshormonal dysplasia and breast cancer].
Zhalgasbaeva GT; Baisheva SA; Ozerova IV; Friazinova TS; Kuralasov AK
Vopr Onkol; 1989; 35(10):1198-203. PubMed ID: 2596063
[TBL] [Abstract][Full Text] [Related]
9. [Circulating immune complexes and immunologic reactivity in breast cancer].
Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG
Eksp Onkol; 1984; 6(3):50-2. PubMed ID: 6333978
[TBL] [Abstract][Full Text] [Related]
10. [B cells and serum immunoglobulins in patients with breast pathology].
Zornoza G; Hernández JL; Sanz ML; Fernández J; Goena I; Lera JM
Rev Esp Oncol; 1981; 28(1):17-27. PubMed ID: 6984973
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
Ghayur T; Seemayer TA; Lapp WS
Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241
[TBL] [Abstract][Full Text] [Related]
12. Circulating killer cells in women undergoing needle-directed excisional breast biopsy.
Ohlsson-Wilhelm BM; Wang G
Eur J Histochem; 1994; 38 Suppl 1():77-82. PubMed ID: 8547715
[TBL] [Abstract][Full Text] [Related]
13. [The lymphocyte immunological phenotype of young and middle-aged breast cancer patients].
Chobanian NS; Letiagin VP; Savel'eva EV; Zabotina TN; Baryshnikov AIu; Kadagidze ZG
Vopr Onkol; 1992; 38(5):548-54. PubMed ID: 1300753
[TBL] [Abstract][Full Text] [Related]
14. [Lymphocytes of the blood, regional lymph nodes and tumor tissue in breast cancer].
Bazhenov SM; Dorosevich AE; Naperstnikov VV
Vopr Onkol; 1988; 34(9):1040-8. PubMed ID: 3055674
[No Abstract] [Full Text] [Related]
15. Identification of T and B lymphocytes in human breast cancer with immunohistochemical techniques.
Schoorl R; Riviere AB; Borne AE; Feltkamp-Vroom TM
Am J Pathol; 1976 Sep; 84(3):529-44. PubMed ID: 183507
[TBL] [Abstract][Full Text] [Related]
16. Cellular and humoral systemic and mucosal immune responses stimulated in volunteers by an oral polybacterial immunomodulator "Dentavax".
Petrunov B; Marinova S; Markova R; Nenkov P; Nikolaeva S; Nikolova M; Taskov H; Cvetanov J
Int Immunopharmacol; 2006 Jul; 6(7):1181-93. PubMed ID: 16714223
[TBL] [Abstract][Full Text] [Related]
17. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
18. [Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer].
Hisamatsu K; Toge T; Yanagawa E; Hamada Y; Seto Y; Yamada H; Toi M; Hattori T
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2555-61. PubMed ID: 2943228
[TBL] [Abstract][Full Text] [Related]
19. [Initial immunologic evaluations in breast and thyroid cancer].
Abeatici S; Mussa A; Levis P; Sandrucci S; Storta P
Minerva Med; 1982 Apr; 73(18):1149-54. PubMed ID: 6979010
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
